RSS   Newsletter   Contact   Advertise with us
Post Online Media

Boston Biomedical appoints Edgar Braendle as vice president

Boston BiomedicalOctober 17, 2017, Cambridge, Mass., USA - Boston Biomedical, a developer of cancer therapeutics, announced the appointment of Edgar Braendle to executive vice president, head of research and development and chief medical officer.
Dr. Braendle previously served as President and CEO of ARUP Laboratories, a national clinical and anatomic pathology reference laboratory.

Prior to this, Dr. Braendle spent more than a decade at Novartis Pharmaceutical Corporation, where he served as Senior Vice President and Global Head of Companion Diagnostics where he led the company's precision medicine approach, delivering complementary and companion diagnostics for Novartis Medicines.

In an earlier role as Vice President, Global Head of Oncology Biologics, Dr. Braendle led the development of oncology biologics in early to late stages, successfully filing eight investigational new drug applications.


 LATEST MOVES FROM Massachusetts 


POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.